Product Information
IMITREX 6 MG/0.5 ML CARTRIDGES is a brand product labeled by GlaxoSmithKline LLC, priced at $437.5630 per ML under NDC 00173047800. Its NADAC has been published 642 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the sumatriptan market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
6 mg/.5mL
Manufacturer
GlaxoSmithKline LLCNDC
00173047800
Classification
Brand
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
SUMATRIPTAN SUCCINATEApproval Type
New Drug (NDA)
FDA Application
NDA020080On Market Since
1/27/1997
Pharmacological Classes
Price Statistics
The NADAC for IMITREX 6 MG/0.5 ML CARTRIDGES has been published 642 times since Nov 28, 2013, and over the history we have for it it has risen 128.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $437.5630 per ML |
|---|---|
| All-time high | $442.6790 (Jul 10, 2024) |
| All-time low | $191.4632 (Nov 28, 2013) |
| 52-week high | $437.5630 |
| 52-week low | $435.9192 |
| Median price | $385.8228 |
| Average price | $368.9527 |
| Largest weekly change | +15.0% (Dec 30, 2015) |
| Weeks tracked | 642 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 97% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IMITREX 6 MG/0.5 ML CARTRIDGES?
The current National Average Drug Acquisition Cost (NADAC) for IMITREX 6 MG/0.5 ML CARTRIDGES, manufactured by GlaxoSmithKline LLC, is $437.5630 per ML (NDC 00173047800), effective Jun 24, 2026.
How has the price of IMITREX 6 MG/0.5 ML CARTRIDGES changed over time?
Over the history we have for it, the NADAC for IMITREX 6 MG/0.5 ML CARTRIDGES has risen 128.5%. It has been tracked across 642 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for IMITREX 6 MG/0.5 ML CARTRIDGES?
Since Nov 28, 2013, the NADAC for IMITREX 6 MG/0.5 ML CARTRIDGES has ranged from a low of $191.4632 (Nov 28, 2013) to a high of $442.6790 (Jul 10, 2024), with a median of $385.8228 per ML.
Are there cheaper alternatives to IMITREX 6 MG/0.5 ML CARTRIDGES?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, SUMATRIPTAN 6 MG/0.5 ML VIAL, is $14.9286 per ML — about 97% below IMITREX 6 MG/0.5 ML CARTRIDGES.
Who manufactures IMITREX 6 MG/0.5 ML CARTRIDGES?
IMITREX 6 MG/0.5 ML CARTRIDGES (NDC 00173047800) is labeled by GlaxoSmithKline LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification